Ovarian granulosa-stromal tumor

Clinical trials for Ovarian granulosa-stromal tumor explained in plain language.

Never miss a new study

Get alerted when new Ovarian granulosa-stromal tumor trials appear

Sign up with your email to follow new studies for Ovarian granulosa-stromal tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug shows promise for rare ovarian cancer in early trial

Disease control Completed

This phase 2 trial tested the drug nirogacestat in 53 people with recurrent ovarian granulosa cell tumors, a rare type of ovarian cancer. The goal was to see if the drug could shrink tumors or slow the disease. Participants took nirogacestat orally, and researchers measured how m…

Matched conditions: OVARIAN GRANULOSA-STROMAL TUMOR

Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC

Ovarian granulosa-stromal tumor

Get alerted when new Ovarian granulosa-stromal tumor trials appear

New drug shows promise for rare ovarian cancer in early trial